Coronavirus treatments—if more women are on the board, it’s likely safer, new study finds

Forbes wrote about a study by IT, Analytics and Operations professor Katie Wowak and her co-researchers, showing highly-defective medical products and treatments are recalled 35% faster when more than one woman is on the board of directors.

Published

Related News & Stories

All News & Stories